Treatment of cutaneous sarcoidosis with tranilast

The Journal of Dermatology
H YamadaS Tajima

Abstract

Tranilast is an anti-allergic drug clinically used for the treatment of atopy or urticaria. The drug has been shown to have an anti-fibrotic effect as well. We treated two cutaneous sarcoidosis patients with tranilast, resulting in remission within three months of administration. This drug should be an excellent tool for the treatment of other granulomatous diseases.

References

Jan 1, 1976·Annals of the New York Academy of Sciences·D G JamesL E Siltzbach
Jan 1, 1985·International Archives of Allergy and Applied Immunology·A KodaM Nakazawa
Jun 1, 1987·Journal of Pharmacobio-dynamics·Y MiyachiY Niwa
Oct 1, 1994·Journal of Biochemistry·H YamadaS R Pinnell

❮ Previous
Next ❯

Citations

Jun 1, 2011·The Journal of Dermatology·Yumi KoikeSoji Yamazaki
Feb 21, 2002·The British Journal of Dermatology·P Bannerjee, C A Holden
Mar 15, 2005·The Journal of Dermatological Treatment·A Mosam, N Morar
Jan 5, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·L WangM Mizoguchi
Apr 24, 1997·The New England Journal of Medicine·L S NewmanL A Maier
May 12, 2007·American Journal of Clinical Dermatology·Vinod KauraClaire S Kaura
Dec 13, 2002·American Journal of Clinical Oncology·Bart FrizzellJoseph Jenrette
Jul 17, 2001·International Journal of Dermatology·R J YoungD M Elston
Apr 21, 1998·Surgery Today·S KinugasaS Sasaki
Apr 20, 2001·Journal of the American Academy of Dermatology·J C EnglishK E Greer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.